A
ApnimedClinical-stage biotech developing Oxnimbi (AD109), the first investigational oral pill for obstructive sleep apnea.
3 Pulse stories
S
SanofiSanofi is a global biopharmaceutical company developing and manufacturing medicines and vaccines across specialty care, immunology, oncology, and rare diseases.
2 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2017
Founded
1973
Cambridge, Massachusetts
HQ
Paris, France
Public (APMD)
Status
Public (SNY)
Apnimed investors
ShionogiColumbia Seligman Technology and Information FundAlpha Wave GlobalMorningside VenturesColumbia ManagementNexPoint Asset ManagementSectoral Asset Management
Sanofi investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Apnimed and Sanofi.